Your Power to Heal
buy.svg
Where to Buy *
buy.svg
Where to Buy *

Respond to the rise of antimicrobial resistance with Cutimed® Sorbact®

The whole world has woken up to the challenge of antimicrobial resistance (AMR). Without effective tools for prevention and adequate treatment of infections, the number of people for whom treatment is failing will increase. Sorbact® Technology wound dressings can form a valuable part of your AMR and Antimicrobial Stewardship strategy.

Using Cutimed® Sorbact® to support Antimicrobial Stewardship 1

This review article presents evidence that supports the integration of dressings that act in a physical manner as an alternative approach to prevent and/or treat infection in wounds. These dressings do not contribute to AMR and support AMS.1

Read more
Image showing a young nurse that looks determined in the camera.
Image showing a microscopic view on how Cutimed® Sorbact® works

Cutimed® Sorbact® reduces the bioburden without antimicrobial agents

Utilizing a physical mode of action, Cutimed® Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing.

Utilizing this physical mode of action, Sorbact® Technology dressings may lower the use of antibiotics and contribute to the management and prevention of wound infection.2 No release of active substances into the wound is expected.

Read more about Sorbact® Technology
Image showing Cutimed® Sorbact® dressing.

Cutimed® Sorbact® is effective against the Top 5 World Health Organization pathogens

In vitro tests showed that Cutimed® Sorbact® DACC™-coated bacteria-binding wound dressing was able to inhibit the growth of all the World Health Organization (WHO) priority pathogens tested3:

  • Acinetobacter baumannii
  • Pseudomonas aeruginosa
  • Enterobacteriaceae (ESBL)
  • Enterococcus faecium (VRE) and Staphylococcus aureus (MRSA)
Read more

EWMA supports Antimicrobial Stewardship

The European Wound Management Association (EWMA) supports AMS by providing practical recommendations for optimizing antimicrobial therapy for the treatment of wound infection. The evidence on Sorbact® Technology dressings aligns with EWMA recommendations and supports AMS in wound treatment.1

The overall aim of the AMS initiatives is to reduce inappropriate use of antibiotics by promoting, facilitating and teaching the use of antibiotic alternatives in wound management across all healthcare settings.

Visit the EWMA project

Cutimed® Sorbact® product range

Offers safe and effective wound infection management without expectation of antimicrobial resistance.

Find a suitable product

References

  1. Rippon MG et al. Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarbamoyl chloride (DACC)-coated wound dressings. J Wound Care. 2021;30:284–296. Read more
  2. Chadwick P & Ousey K. Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review. J Wound Care. 2019;28:370-382. Read more
  3. Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006). Read more